Pancratistatin
CAS: 96203-70-2
Ref. 3D-WDA20370
5mg | Nachfragen | ||
10mg | Nachfragen | ||
25mg | Nachfragen | ||
50mg | Nachfragen |
Produktinformation
- (+)-Pancratistatin
- (1R,2S,3S,4S,4aR,11bR)-1,3,4,4a,5,11b-Hexahydro-1,2,3,4,7-pentahydroxy[1,3]dioxolo[4,5-j]phenanthridin-6(2H)-one
- NSC 349156
- Pancratistatine
- [1,3]Dioxolo[4,5-j]phenanthridin-6(2H)-one, 1,3,4,4a,5,11b-hexahydro-1,2,3,4,7-pentahydroxy-, [1R-(1α,2β,3α,4α,4aα,11bβ)]-
- [1,3]dioxolo[4,5-j]phenanthridin-6(2H)-one, 1,3,4,4a,5,11b-hexahydro-1,2,3,4,7-pentahydroxy-, (1R,2S,3S,4S,4aR,11bR)-
- [1,3]dioxolo[4,5-j]phenanthridine-1,2,3,4,6,7-hexol, 1,2,3,4,4a,11b-hexahydro-, (1R,2S,3S,4S,4aR,11bR)-
Pancratistatin is a naturally occurring compound with potent medicinal properties. It has been shown to induce apoptosis, or programmed cell death, in a variety of cancer cell lines, making it a promising candidate for the development of anticancer therapies. Pancratistatin works by inhibiting kinases and other proteins that are involved in tumor growth and survival. It has been found to be effective against leukemia cells and has also shown promise as an inhibitor of Chinese hamster ovary cells. Additionally, pancratistatin can be isolated from urine samples, making it a potentially valuable diagnostic tool for detecting cancer. With its powerful anticancer properties, pancratistatin represents a promising avenue for the development of new cancer treatments.
Chemische Eigenschaften
Technische Anfrage zu: 3D-WDA20370 Pancratistatin
Wenn Sie ein Angebot anfordern oder eine Bestellung aufgeben möchten, legen Sie stattdessen die gewünschten Produkte in Ihren Warenkorb und fordern Sie dann ein Angebot oder eine Bestellung an aus dem Warenkorb. Es ist schneller, billiger und Sie können von den verfügbaren Rabatten und anderen Vorteilen profitieren.